Position history for AXA Investment Managers S.A.'s holdings in MoonLake Immunotherapeutics
AXA Investment Managers S.A. holds 60,755 shares of MLTX (MoonLake Immunotherapeutics), worth $435,613 as of 2025-Q3. This is a new position. MLTX represents 0.0% of AXA Investment Managers S.A.'s portfolio.
Current Value
$435,613
Current Shares
60,755
Total Value Change
$0
Total Shares Change
0
Other major holders of MLTX: FMR LLC, Avoro Capital Advisors LLC
New |
| 60,755 |
- |
| $435,613 |
| 0.0% |
| $6.24 |
33 |